PHARMALINK CONSULTING LIMITED

03505088
Dissolved London

Other professional, scientific and technical activities n.e.c.

2 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
P

PHARMALINK CONSULTING LIMITED

03505088

Other professional, scientific and technical activities n.e.c.

Founded 5 Feb 1998 Dissolved London, England 2 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
Accounts Submitted 9 Oct 2024
Confirmation Submitted 5 Feb 2025 Next due 19 Feb 2026 5 months overdue
Net assets £225K £5M 2023 year on year
Total assets £874K £10M 2023 year on year
Total Liabilities £649K £5M 2023 year on year
Charges 5
2 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

6 Lloyds Avenue Suite 4cl London EC3N 3AX England

Website

www.example.com

Full company profile for PHARMALINK CONSULTING LIMITED (03505088), a dissolved life sciences and medical technology company based in London, England. Incorporated 5 Feb 1998. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts
Due by

Balance Sheet & P&L (2014–2023)

Cash in Bank

£563.54k

Decreased by £3.03M (-84%)

Net Assets

£225.43k

Decreased by £5.26M (-96%)

Total Liabilities

£648.92k

Decreased by £4.58M (-88%)

Turnover

N/A

Employees

2

Debt Ratio

74%

Increased by 25 (+51%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Genpact Luxembourg S. À R.l.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Genpact Limited

Bermuda

Active
Notified 8 Aug 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Ceased

Group Structure

Group Structure

PHARMALINK CONSULTING LIMITED Current Company

Charges

Charges

2 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 May 2025GazetteGazette Dissolved Voluntary
4 Mar 2025GazetteGazette Notice Voluntary
19 Feb 2025DissolutionDissolution Application Strike Off Company
5 Feb 2025Confirmation StatementConfirmation statement made on 5 Feb 2025 with updates
9 Oct 2024AccountsAnnual accounts made up to 31 Dec 2023
20 May 2025 Gazette

Gazette Dissolved Voluntary

4 Mar 2025 Gazette

Gazette Notice Voluntary

19 Feb 2025 Dissolution

Dissolution Application Strike Off Company

5 Feb 2025 Confirmation Statement

Confirmation statement made on 5 Feb 2025 with updates

9 Oct 2024 Accounts

Annual accounts made up to 31 Dec 2023

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 20 May 2025

Gazette Notice Voluntary

1 years ago on 4 Mar 2025

Dissolution Application Strike Off Company

1 years ago on 19 Feb 2025

Confirmation statement made on 5 Feb 2025 with updates

1 years ago on 5 Feb 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 9 Oct 2024